Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v5-EN
Language English English
Date Updated 2021-11-24 2021-11-15
Drug Identification Number 02326302 02326302
Brand name BI-PEGLYTE BI-PEGLYTE
Common or Proper name Bowel Prep Kit – PEG 3350 and Electrolytes for Oral Solution USP and Bisacodyl Delayed-Released Tablets USP Bowel Prep Kit – PEG 3350 and Electrolytes for Oral Solution USP and Bisacodyl Delayed-Released Tablets USP
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC PENDOPHARM DIVISION OF PHARMASCIENCE INC
Ingredients POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM BICARBONATE SODIUM SULFATE POLYETHYLENE GLYCOL 3350 BISACODYL POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM BICARBONATE SODIUM SULFATE POLYETHYLENE GLYCOL 3350 BISACODYL
Strength(s) 0.76G 1.46G 1.69G 5.74G 59.55G 5MG 0.76G 1.46G 1.69G 5.74G 59.55G 5MG
Dosage form(s) POWDER FOR SOLUTION KIT TABLET (DELAYED-RELEASE) POWDER FOR SOLUTION KIT TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 2x70g 2x70g
ATC code A06AB A06AB
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-09-30 2021-09-30
Estimated end date 2021-12-10 2021-12-10
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments *** Update Nov 24, 2021: Limited stock now available ***
Health Canada comments